ÿþ<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> <html> <head> <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> <title>EASL 2010 - Poster Presentations</title> <link rel="stylesheet" type="text/css" href="style.css"> </head> <body> <table width="750" align="center" border="0" cellspacing="0" cellpadding="0" class="MainTable"> <tr> <td><img src="http://www2.kenes.com/liver-congress/PublishingImages/top_ei.jpg" width="760" height="129" /></td> </tr> <tr> <td class="content"><h1>Poster Presentations</h1> <P><b><u>Apr 17, 2010</u></b></P><p align=right><em>Poster Board Number</em></p><H2>Category 4. MOLECULAR AND CELLULAR BIOLOGY:<br /></H2><table><tr> <td><a href='Abstract798.htm'><B>DIFFERENTIATION OF TRANSFECTED HUMAN UMBILICAL CORD BLOOD STEM CELLS IN THE REGENERATING LIVER OF RATS</B></a> </em><br> <b>D. Andreeva</b><sup>1</sup>*, I. Gazizov<sup>1</sup>, T. Ilmaz<sup>1</sup>, M. Kaligin<sup>1</sup>, A. Gumerova<sup>1</sup>, A. Kiyasov<sup>1</sup>, A. Rizvanov<sup>2</sup><br> <em><sup>1</sup>Kazan State Medical University, <sup>2</sup>Kazan State University, Kazan, Russia. *goober@mail.ru</em></td><td valign=top><em>911 </td></tr> <tr> <td><a href='Abstract799.htm'><B>UDCA UP-REGULATES HUMAN PLACENTAL OATP-A MRNA EXPRESSION</B></a> </em><br> <b>F. Azzaroli</b><sup>1</sup>*, A. Mennone<sup>2</sup>, M.E. Raspanti<sup>1</sup>, M.L. Longo<sup>1</sup>, L. Turco<sup>1</sup>, F. Buonfiglioli<sup>1</sup>, M. Giandinoto<sup>1</sup>, E. Roda<sup>1</sup>, N. Mazzella<sup>1</sup>, F. Lodato<sup>1</sup>, M. Montagnani<sup>1</sup>, J.L. Boyer<sup>2</sup>, G. Mazzella<sup>1</sup><br> <em><sup>1</sup>Clinical Medicine, University of Bologna, Bologna, Italy, <sup>2</sup>Internal Medicine, Liver Center, University of Yale, New Haven, CT, USA. *francesco.azzaroli@unibo.it</em></td><td valign=top><em>912 </td></tr> <tr> <td><a href='Abstract800.htm'><B>THERAPEUTIC EFFECTS OF FXR AND TGR5 ACTIVATION IN THE MDR2 (ABCB4)<SUP>-/-</SUP> MOUSE MODEL OF SCLEROSING CHOLANGITIS</B></a> </em><br> <b>A. Baghdasaryan</b><sup>1</sup>*, T. Claudel<sup>1</sup>, J. Gumhold<sup>1</sup>, D. Silbert<sup>1</sup>, S. Halsegger<sup>1</sup>, R. Völkl<sup>1</sup>, L. Adorini<sup>2</sup>, P. Fickert<sup>1</sup>, M. Trauner<sup>1</sup><br> <em><sup>1</sup>Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University Graz, Graz, Austria, <sup>2</sup>Intercept Pharmaceuticals, Perugia, Italy. *anna.baghdasaryan@klinikum-graz.at</em></td><td valign=top><em>913 </td></tr> <tr> <td><a href='Abstract801.htm'><B>CELL-SPECIFIC TARGETING OF INTERFERON GAMMA TO HEPATIC STELLATE CELLS USING A CYCLIC PDGF-RECEPTOR RECOGNIZING PEPTIDE IMPROVES ITS THERAPEUTIC EFFICACY</B></a> </em><br> <b>R. Bansal</b>*, J. Prakash, E. Post, L. Beljaars, K. Poelstra<br> <em>Department of Pharmacokinetics, Toxicology and Targeting, Graduate School for Drug Exploration (GUIDE), University of Groningen, Groningen, The Netherlands. *r.bansal@rug.nl</em></td><td valign=top><em>914 </td></tr> <tr> <td><a href='Abstract802.htm'><B>INTRIGUING RELATIONSHIP BETWEEN VITAMIN D AND LIVER FIBROSIS</B></a> </em><br> <b>A. Beilfuss</b><sup>1</sup>*, R.K. Gieseler<sup>1,2</sup>, A. Zahn<sup>1</sup>, G. Marquitan<sup>1,2</sup>, P. Kocabayoglu<sup>1</sup>, G. Gerken<sup>1</sup>, S.L. Friedman<sup>3</sup>, A.E. Canbay<sup>1</sup><br> <em><sup>1</sup>Department of Gastroenterology and Hepatology, University Hospital Essen, Essen, <sup>2</sup>Division of R&D, Rodos BioTarget GmbH, Hannover, Germany, <sup>3</sup>Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA. *anja.beilfuss@stud.uni-due.de</em></td><td valign=top><em>915 </td></tr> <tr> <td><a href='Abstract803.htm'><B>PHARMACOLOGICAL ANTAGONISM OF THE CHEMOKINE CCL5 (RANTES) AMELIORATES EXPERIMENTAL LIVER FIBROSIS <I>IN VIVO</I></B></a> </em><br> <b>M.-L. Berres</b><sup>1</sup>*, M. Moreno Zaldivar<sup>1</sup>, R. Koenen<sup>2</sup>, P. Schmitz<sup>1</sup>, C. Weber<sup>2</sup>, C. Trautwein<sup>1</sup>, H.E. Wasmuth<sup>1</sup><br> <em><sup>1</sup>Medical Department III, <sup>2</sup>Institute of Molecular Cardiovascular Research, University Hospital of Aachen, Aachen, Germany. *mberres@ukaachen.de</em></td><td valign=top><em>916 </td></tr> <tr> <td><a href='Abstract804.htm'><B>THE IMPACT OF ELEVATION OF TOTAL BILIRUBIN LEVEL ON SERUM <I>N</I>-GLYCOSYLATION PATTERNS IN MICE AND MEN</B></a> </em><br> <b>B. Blomme</b><sup>1</sup>*, C. Van Steenkiste<sup>1</sup>, J. Van Huysse<sup>2</sup>, I. Colle<sup>1</sup>, N. Callewaert<sup>3,4</sup>, H. Van Vlierberghe<sup>1</sup><br> <em><sup>1</sup>Gastroenterology and Hepatology, Ghent University Hospital, Ghent, <sup>2</sup>Pathology, AZ Sint-Jan Brugge, Brugge, <sup>3</sup>Molecular Biomedical Research, VIB, <sup>4</sup>Biochemistry, Physiology and Microbiology, Ghent University, Ghent, Belgium. *bram.blomme@ugent.be</em></td><td valign=top><em>917 </td></tr> <tr> <td><a href='Abstract805.htm'><B>PERISINUSOIDAL FIBROSIS IS ASSOCIATED WITH CHANGES IN SINUSOIDAL ENDOTHELIAL CELL (SEC) PHENOTYPE SUGGESTIVE OF A TRANSDIFFERENTIATION PROCESS</B></a> </em><br> <b>G. Borghi-Scoazec</b><sup>1</sup>*, S. Collardeau-Frachon<sup>1</sup>, J. Dumortier<sup>2</sup>, J.-Y. Scoazec<sup>1</sup><br> <em><sup>1</sup>Pathology, <sup>2</sup>Hepatogastroenterology, Hopital Edouard Herriot, Lyon, France. *giovanna.borghi-scoazec@chu-lyon.fr</em></td><td valign=top><em>918 </td></tr> <tr> <td><a href='Abstract806.htm'><B>ZONAL ENDOTHELIAL CELL HETEROGENEITY IN THE HUMAN HEPATIC LOBULE: FURTHER EVIDENCE AND PHYSIOPATHOLOGICAL CONSEQUENCES</B></a> </em><br> <b>G. Borghi-Scoazec</b>*, J.-Y. Scoazec<br> <em>Pathology, Hopital Edouard Herriot, Lyon, France. *giovanna.scoazec@chu-lyon.fr</em></td><td valign=top><em>919 </td></tr> <tr> <td><a href='Abstract807.htm'><B>ANTIFIBROTIC PROPERTIES OF NOV/CCN3 IN LIVER </B></a> </em><br> <b>E. Borkham-Kamphorst</b><sup>1</sup>*, J. Herrmann<sup>2</sup>, W. Bohr<sup>1</sup>, E. van de Leur<sup>1</sup>, R. Weiskirchen<sup>1</sup><br> <em><sup>1</sup>Institute of Clinical Chemistry and Pathobiochemistry, RWTH University Hospital Aachen, Aachen, <sup>2</sup>Institute of Physiology, University of Veterinary Medicine Hannover, Hannover, Germany. *ekamphorst@ukaachen.de</em></td><td valign=top><em>920 </td></tr> <tr> <td><a href='Abstract808.htm'><B>PANGENOMIC PROFILING INDICATES DISTINCT FUNCTIONS OF PORTAL AND HEPATIC STELLATE CELLS-DERIVED RAT LIVER MYOFIBROBLASTS IN WOUND HEALING </B></a> </em><br> <b>N. Bosselut</b><sup>1,2,3</sup>*, V. Barbu<sup>1,2</sup>, C. Henegar<sup>2,4</sup>, C. Rey<sup>1</sup>, P.-Y. Boelle<sup>5</sup>, D. Wendum<sup>2,6</sup>, B. Baudin<sup>3</sup>, M. Vaubourdolle<sup>3</sup>, K. Clément<sup>2,4</sup>, A. Cadoret<sup>1</sup>, C. Housset<sup>1,2</sup><br> <em><sup>1</sup>Inserm UMR_S938, CDR Saint-Antoine, <sup>2</sup>UPMC Univ Paris 06, <sup>3</sup>Biochemistry Laboratory, Saint-Antoine Hospital, AP-HP, <sup>4</sup>Inserm UMR_S872, Cordeliers Research Center, <sup>5</sup>Inserm U707, <sup>6</sup>Department of Pathology, Saint-Antoine Hospital, AP-HP, Paris, France. *nelly.bosselut@htd.aphp.fr</em></td><td valign=top><em>921 </td></tr> <tr> <td><a href='Abstract809.htm'><B>MULTIPOTENT STEM CELLS RESIDE IN HUMAN EXTRAHEPATIC BILE DUCTS AND CAN GIVE RISE TO HEPATOCYTES, CHOLANGIOCYTES AND PANCREATIC ISLET CELLS </B></a> </em><br> <b>V. Cardinale</b><sup>1,2</sup>*, Y. Wang<sup>3</sup>, G. Carpino<sup>4</sup>, M. Gatto<sup>1,2</sup>, G. Mendel<sup>3</sup>, G. Mennini<sup>5</sup>, M. Rossi<sup>5</sup>, P.B. Berloco<sup>5</sup>, E. Gaudio<sup>6</sup>, L.M. Reid<sup>3</sup>, D. Alvaro<sup>1,2</sup><br> <em><sup>1</sup>Clinical Medicine, Sapienza, University of Rome, Rome, <sup>2</sup>Polo Pontino, Sapienza, University of Rome, Latina, Italy, <sup>3</sup>School of Medicine, University of North Carolina, Chapel Hill, NC, USA, <sup>4</sup>Science of Health, University of Rome Foro Italico, <sup>5</sup>Surgery Science 'Paride Stefanini', <sup>6</sup>Human Anatomy, Sapienza, University of Rome, Rome, Italy. *v.cardinale80@gmail.com</em></td><td valign=top><em>922 </td></tr> <tr> <td><a href='Abstract810.htm'><B>HEPARANASE ACCELERATES PROLIFERATION OF BOTH HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS AFTER PARTIAL HEPATECTOMY DESPITE IL-6 AND TNF-</B><B>A </B><B>DOWN REGULATION</B></a> </em><br> <b>J. Carmel</b><sup>1</sup>*, A. Arish<sup>2</sup>, N. Ilan<sup>3</sup>, G. Shoshany<sup>4</sup>, I. Vlodavsky<sup>3</sup>, Y. Baruch<sup>1,5</sup><br> <em><sup>1</sup>Liver Unit, <sup>2</sup>Department of Surgery B, Rambam - Health Care Campus, <sup>3</sup>Vascular and Tumor Biology Research Center, Bruce Rappaport Faculty, Technion-Israel Institute of Technology, <sup>4</sup>Department of Pediatric Surgery, Rambam - Health Care Campus, <sup>5</sup>Bruce Rappaport Faculty, Technion-Israel Institute of Technology, Haifa, Israel. *jcbook@gmail.com</em></td><td valign=top><em>923 </td></tr> <tr> <td><a href='Abstract811.htm'><B>CF102 INDUCES APOPTOSIS OF LIVER CANCER WHILE PREVENTING APOPTOSIS IN LIVER INFLAMMATION: A NEW APPROACH TO TREAT LIVER DISEASES </B></a> </em><br> <b>S. Cohen</b><sup>1</sup>*, S.M. Stemmer<sup>2</sup>, G. Zozulya<sup>3</sup>, A. Ochaion<sup>3</sup>, R. Patoka<sup>3</sup>, F. Barer<sup>3</sup>, S. Bar Yehuda<sup>3</sup>, L. Rath-Wolfson<sup>4</sup>, P. Fishman<sup>3</sup><br> <em><sup>1</sup>Can-Fite BioPharma, Petach -Tikva, <sup>2</sup>Institute of Oncology, Davidoff Center, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, <sup>3</sup>Can-Fite BioPharma, <sup>4</sup>Department of Pathology, Rabin Medical Center, Golda Campus, Sackler Faculty of Medicine, Tel-Aviv University, Petach-Tikva, Israel. *sara@canfite.co.il</em></td><td valign=top><em>924 </td></tr> <tr> <td><a href='Abstract812.htm'><B>HUMAN FETAL LIVER PROGENITOR CELLS AND THEIR IN-VIVO DIFFERENTIATION</B></a> </em><br> <b>Y.Y. Dan</b><sup>1</sup>*, H. Hung<sup>2</sup>, P. Wong<sup>3</sup>, S.G. Lim<sup>1</sup><br> <em><sup>1</sup>Gastroenterology and Hepatology, National University Health System, <sup>2</sup>NUHS, <sup>3</sup>Obstetrics and Gynecology, NUHS, Singapore, Singapore. *mdcdyy@nus.edu.sg</em></td><td valign=top><em>925 </td></tr> <tr> <td><a href='Abstract813.htm'><B>A DIFFERENT VIEW OF THE STEM CELL NICHE IN NORMAL HUMAN LIVER, A CONFOCAL MICROSCOPIC CHARACTERIZATION</B></a> </em><br> <b>K. DezsQ</b>*, S. Paku, E. Bugyik, P. Nagy<br> <em>First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary. *dkata@korb1.sote.hu</em></td><td valign=top><em>926 </td></tr> <tr> <td><a href='Abstract814.htm'><B>ER-STRESS ACTIVATION IN HUMAN HEPATOCELLULAR CANCER CELLS: AN ALTERNATIVE DEATH PATHWAY INDUCED BY PANOBINOSTAT</B></a> </em><br> <b>P. Di Fazio</b>*, R. Montalbano, K. Quint, M. Ocker<br> <em>Institute for Surgical Research, Philipps University Marburg, Marburg, Germany. *difazio@med.uni-marburg.de</em></td><td valign=top><em>927 </td></tr> <tr> <td><a href='Abstract815.htm'><B>DEFICIENCY OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AGGRAVATES INFLAMMATION AND FIBROSIS IN EXPERIMENTAL NON ALCOHOLIC STEATOHEPATITIS BUT PROTECTS AGAINST BILE DUCT LIGATION INDUCED FIBROSIS <I>IN VIVO</I> </B></a> </em><br> <b>K. Dostert</b>*, R. Wiest, J. Schölmerich, C. Hellerbrand, E. Gäbele<br> <em>Klinik und Poliklinik für Innere Medizin I; Klinikum der Universität Regensburg, Regensburg, Germany. *karin.dostert@klinik.uni-regensburg.de</em></td><td valign=top><em>928 </td></tr> <tr> <td><a href='Abstract816.htm'><B>ANTI-OXIDANT CURATIVE EFFECT OF A MANUFACTURED HIP/PAP PROTEIN AGAINST FULMINANT HEPATITIS</B></a> </em><br> N. Moniaux<sup>1,2</sup>, H. Song<sup>1,2</sup>, M. Darnaud<sup>1,2</sup>, K. Garbin<sup>1,2</sup>, M. Gigou<sup>1,2</sup>, C. Mitchell<sup>3,4</sup>, D. Samuel<sup>1,2,5</sup>, P. Amouyal<sup>6</sup>, G. Amouyal<sup>6</sup>, C. Brechot<sup>1,2,7</sup>, <b>J. Faivre</b><sup>1,2</sup>*<br> <em><sup>1</sup>Unite 785, INSERM, <sup>2</sup>UMR-S785, Univ Paris-Sud, Villejuif, <sup>3</sup>Unite 567, INSERM, <sup>4</sup>Université Paris Descartes, Paris, <sup>5</sup>Centre Hepato-Biliaire, AP-HP Hopital Paul Brousse, Villejuif, <sup>6</sup>ALFACT Innovation, Paris, <sup>7</sup>Merieux Alliance, Lyon, France. *nicolas.moniaux@inserm.fr</em></td><td valign=top><em>929 </td></tr> <tr> <td><a href='Abstract817.htm'><B>IDENTIFICATION OF MICRORNAS DURING RAT LIVER REGENERATION AFTER PARTIAL HEPATECTOMY AND MODULATION BY URSODEOXYCHOLIC ACID</B></a> </em><br> R.E. Castro<sup>1</sup>, X. Zhang<sup>2</sup>, <b>D.M. Ferreira</b><sup>1</sup>*, P.M. Borralho<sup>1</sup>, A.L. Sarver<sup>2</sup>, Y. Zeng<sup>2</sup>, C.J. Steer<sup>2</sup>, B.T. Kren<sup>2</sup>, C.M.P. Rodrigues<sup>1</sup><br> <em><sup>1</sup>University of Lisbon, Lisbon, Portugal, <sup>2</sup>University of Minnesota, Minneapolis, MN, USA. *ruieduardocastro@ff.ul.pt</em></td><td valign=top><em>930 </td></tr> <tr> <td><a href='Abstract818.htm'><B>HEPATIC MITOCHONDRIA OBTAINED FROM 6-OHDA-LESIONED PARKINSONIAN RATS EXHIBIT DECREASED ENERGY CAPACITY AND MEMBRANE POTENTIAL</B></a> </em><br> M. Vairetti<sup>1</sup>, <b>A. Ferrigno</b><sup>1</sup>*, V. Rizzo<sup>2</sup>, G. Ambrosi<sup>3</sup>, A. Bianchi<sup>1</sup>, P. Richelmi<sup>1</sup>, F. Blandini<sup>3</sup>, M.T. Armentero<sup>3</sup><br> <em><sup>1</sup>Internal Medicine and Therapeutics, <sup>2</sup>Biochemistry, IRCCS San Matteo, University of Pavia, <sup>3</sup>Interdepartmental Research Center for Parkinson's Disease - Lab. Functional Neurochemistry, IRCCS Neurological Institute C. Mondino, Pavia, Italy. *andreaferrigno@gmail.com</em></td><td valign=top><em>931 </td></tr> <tr> <td><a href='Abstract819.htm'><B>THE THERAPEUTIC EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON CCL<SUB>4</SUB>-INDUCED NECROSIS AND APOPTOSIS IN RAT LIVER</B></a> </em><br> A. Kukner<sup>1</sup>, F. Tore<sup>2</sup>, <b>T. Firat</b><sup>1</sup>*, E.H. Terzi<sup>1</sup>, H. Oner<sup>3</sup>, Y. Balaban<sup>4</sup>, C. Ozogul<sup>5</sup><br> <em><sup>1</sup>Histology and Embryology, Abant Izzet Baysal University, Faculty of Medicine, <sup>2</sup>Physiology, Abant Izzet Baysal University, Bolu, <sup>3</sup>Histology and Embryology, Mehmet Akif University, Faculty of Veterinary Medicine, Burdur, <sup>4</sup>Gastroenterology, Hacettepe University, Faculty of Medicine, <sup>5</sup>Histology and Embryology, Gazi University, Faculty of Medicine, Ankara, Turkey. *tulins2000@gmail.com</em></td><td valign=top><em>932 </td></tr> <tr> <td><a href='Abstract820.htm'><B>MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT</B></a> </em><br> <b>F. Fornari</b><sup>1</sup>*, L. Gramantieri<sup>1</sup>, M. Milazzo<sup>1</sup>, D. Pollutri<sup>1</sup>, G.L. Grazi<sup>1</sup>, M. Negrini<sup>2</sup>, L. Bolondi<sup>1</sup><br> <em><sup>1</sup>University of Bologna, Bologna, <sup>2</sup>University of Ferrara, Ferrara, Italy. *fornarifrancesca@live.it</em></td><td valign=top><em>933 </td></tr> <tr> <td><a href='Abstract821.htm'><B>CORD BLOOD MONONUCLEAR CELLS CAN BE A SOURCE OF HEPATOCYTE AND KUPFER CELL RESTORATION AFTER PARTIAL HEPATECTOMY IN RATS</B></a> </em><br> <b>I.M. Gazizov</b>*, D.I. Andreeva, M.S. Kaligin, A.V. Tabanakova, A.A. Gumerova, A.P. Kiassov<br> <em>Human Anatomy, Kazan State Medical University, Kazan, Russia. *pf.aziz@gmail.com</em></td><td valign=top><em>934 </td></tr> <tr> <td><a href='Abstract822.htm'><B>THE ROLE OF THE NF-</B><B>º</B><B>B SUBUNIT RELA/P65 IN LIVER REGENERATION AFTER PARTIAL HEPATECTOMY IN MICE</B></a> </em><br> M. Ringelhan, S. Krutsch, R.M. Schmid, <b>F. Geisler</b>*<br> <em>2nd Medical Dept., Klinikum rechts der Isar, TU-München, Munich, Germany. *fabian.geisler@lrz.tum.de</em></td><td valign=top><em>935 </td></tr> <tr> <td><a href='Abstract823.htm'><B>C-MET AND GP130 MEDIATE ANTIBACTERIAL SIGNALLING DURING CHOLESTATIC LIVER INJURY VIA TLR4 AND THE INDUCTION OF THE ACUTE-PHASE RESPONSE</B></a> </em><br> <b>A. Giebeler</b><sup>1</sup>*, M. Kaldenbach<sup>1</sup>, S. Erschfeld<sup>1</sup>, C. Birchmeier<sup>2</sup>, C. Trautwein<sup>1</sup>, K. Streetz<sup>1</sup><br> <em><sup>1</sup>Medical Clinic 3, University Hospital Aachen, RWTH Aachen, Aachen, <sup>2</sup>Max Delbrück Centre for Molecular Medicine, Berlin, Germany. *agiebeler@ukaachen.de</em></td><td valign=top><em>936 </td></tr> <tr> <td><a href='Abstract824.htm'><B>GROWTH HORMONE RECEPTOR PLAYS A CRITICAL ROLE IN LIVER REGENERATION VIA THE EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY</B></a> </em><br> A. Zerrad-Saadi<sup>1</sup>, M. Lambert-Blot<sup>1</sup>, H. Bretes-Rodrigues<sup>1</sup>, C. Mitchell<sup>1</sup>, A. Sotiropoulos<sup>2</sup>, J.J. Kopchick<sup>3</sup>, <b>H. Gilgenkrantz</b><sup>1</sup>*, J.-E. Guidotti<sup>1</sup><br> <em><sup>1</sup>Metabolism, Endocrinology and Cancer, <sup>2</sup>Genetique and Development, Institut Cochin, Inserm U567, CNRS UMR8104, Université Paris V, Paris, France, <sup>3</sup>Edison Biotechnology Institute, Molecular and Cellular Biology Program, Ohio University, Athens, OH, USA. *helene.gilgenkrantz@inserm.fr</em></td><td valign=top><em>937 </td></tr> <tr> <td><a href='Abstract825.htm'><B>GLUCOSYLCERAMIDE INHIBIT IL-6/STAT3 SIGNALING PATHWAY AND LEADS TO AN IMPAIRMENT OF LIVER REGENERATION </B></a> </em><br> <b>I. Gretchen</b><sup>1</sup>*, R. Sandhoff<sup>2</sup>, M. Gonzalez-Carmona<sup>1</sup>, S. Weber<sup>3</sup>, R. Büttner<sup>1</sup>, F. Lammert<sup>3</sup>, T. Sauerbruch<sup>1</sup>, Y. Yildiz<sup>1</sup><br> <em><sup>1</sup>University Clinic of Bonn, Bonn, <sup>2</sup>German Cancer Research Center Heidelberg, Heidelberg, <sup>3</sup>Saarland Universiy Hostpital, Homburg, Germany. *yildiz.yildiz@ukb.uni-bonn.de</em></td><td valign=top><em>938 </td></tr> <tr> <td><a href='Abstract826.htm'><B>HEPATOCYTES AND HEPATIC STELLATE CELLS HAVE PROPERTIES OF STEM/PROGENITOR CELLS DURING PRENATAL DEVELOPMENT AND LIVER REGENERATION</B></a> </em><br> <b>A. Gumerova</b>*, A. Kiassov, M. Kaligin, I. Gazizov, M. Titova, D. Andreeva, S. Abdulkhakov, T. Yilmaz, M. Mavlikeev<br> <em>Normal Human Anatomy, Kazan State Medical University, Kazan, Russia. *anissagum@mail.ru</em></td><td valign=top><em>939 </td></tr> <tr> <td><a href='Abstract827.htm'><B>MICRO RNAS IN MOUSE LIVER REGENERATION</B></a> </em><br> <b>I.G. Habeos</b><sup>1</sup>*, P.G. Ziros<sup>1</sup>, I. Chaveles<sup>2</sup>, D. Chartoumpekis<sup>1</sup>, I. Maroulis<sup>2</sup>, D. Karabias<sup>2</sup><br> <em><sup>1</sup>University of Patras, Medical School, <sup>2</sup>Surgery, University of Patras, Medical School, Patras, Greece. *ihabeos@med.upatras.gr</em></td><td valign=top><em>940 </td></tr> <tr> <td><a href='Abstract828.htm'><B>REGULATION OF THE HEPATOCELLULAR RESPONSE TO ENDOPLASMIC RETICULUM STRESS BY THE TRANSCRIPTION FACTOR C-JUN/AP-1</B></a> </em><br> M. Fuest, K. Willim, H.E. Blum, <b>P. Hasselblatt</b>*<br> <em>Dept. of Medicine II, Freiburg University Hospital, Freiburg, Germany. *peter.hasselblatt@uniklinik-freiburg.de</em></td><td valign=top><em>941 </td></tr> <tr> <td><a href='Abstract829.htm'><B>UNEXPECTED ANTI-FIBROTIC EFFECTS OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) IN EXPERIMENTAL LIVER FIBROSIS</B></a> </em><br> <b>D. Heinrichs</b><sup>1</sup>*, M. Jung<sup>2</sup>, C. Offermanns<sup>1</sup>, P. Schmitz<sup>1</sup>, C. Trautwein<sup>1</sup>, J. Bernhagen<sup>2</sup>, H.E. Wasmuth<sup>1</sup><br> <em><sup>1</sup>Medizinische Klinik III, <sup>2</sup>Biochemie und Zellbiologie, Universitätsklinikum Aachen, Aachen, Germany. *dheinrichs@ukaachen.de</em></td><td valign=top><em>942 </td></tr> <tr> <td><a href='Abstract830.htm'><B>CONTRIBUTION OF NK AND NKT CELLS IN HEPATIC REGENERATION AFTER PARTIAL HEPATECTOMY IN MICE</B></a> </em><br> <b>S. Hosoya</b><sup>1</sup>*, K. Ikejima<sup>1</sup>, T. Aoyama<sup>1</sup>, S. Ishikawa<sup>1</sup>, H. Yamagata<sup>1</sup>, K. Kon<sup>1</sup>, K. Takeda<sup>2</sup>, S. Watanabe<sup>1</sup><br> <em><sup>1</sup>Department of Gastroenterology, <sup>2</sup>Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan. *shosoya@juntendo.ac.jp</em></td><td valign=top><em>943 </td></tr> <tr> <td><a href='Abstract831.htm'><B>THERAPEUTIC POTENTIAL OF HUMAN PLACENTA-DERIVED STEM CELLS IN THE CCL<SUB>4</SUB>-INJURED RATS DEPENDS ON TRANSPLANTATION ROUTES</B></a> </em><br> G.J. Kim<sup>1</sup>, <b>S.G. Hwang</b><sup>2,3</sup>*, J. Jung<sup>1</sup>, M.J. Lee<sup>4</sup>, G.I. Kim<sup>3,5</sup>, S.W. Kwon<sup>6</sup>, K.S. Rim<sup>2,3</sup><br> <em><sup>1</sup>Department of Biomedical Science, CHA University, Seoul, <sup>2</sup>Department of Internal Medicine, CHA Bundang Medical Center, CHA University, <sup>3</sup>Institue for Clinical Research, CHA University, Seongnam, <sup>4</sup>School of Veterinary Medicine, Kangwon National University, Chuncheon, <sup>5</sup>Department of Pathology, <sup>6</sup>Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea. *sghwang@cha.ac.kr</em></td><td valign=top><em>944 </td></tr> <tr> <td><a href='Abstract832.htm'><B><I>IN VITRO</I> DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO FUNCTIONAL HEPATOCYTES USING A MESENCHYMAL CELL LINE DERIVED FROM MURINE FETAL LIVERS</B></a> </em><br> <b>T. Ishii</b><sup>1,2</sup>*, K. Yasuchika<sup>1</sup>, K. Fukumitsu<sup>1,2</sup>, T. Kawamoto<sup>3</sup>, Y. Amagai<sup>3</sup>, R. Kamimura<sup>1</sup>, N. Sasaki<sup>1</sup>, I. Ikai<sup>1,4</sup>, E. Kawase<sup>5</sup>, H. Suemori<sup>2</sup>, N. Nakatsuji<sup>5,6</sup>, S. Uemoto<sup>1</sup><br> <em><sup>1</sup>Department of Surgery, Graduate School of Medicine Kyoto University, <sup>2</sup>Laboratory of Embryonic Stem Cell Research, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, <sup>3</sup>Stem Cell and Drug Discovery Institute, <sup>4</sup>Department of Surgery, Kyoto Medical Center, National Hospital Organization, <sup>5</sup>Department of Development and Differentiation, Institute for Frontier Medical Sciences, <sup>6</sup>Institute for Integrated Cell-Material Science, Kyoto University, Kyoto, Japan. *taishii@kuhp.kyoto-u.ac.jp</em></td><td valign=top><em>945 </td></tr> <tr> <td><a href='Abstract833.htm'><B>THE HGF/C-MET SYSTEM PLAYS A CENTRAL ROLE FOR LIVER REPOPULATION BY TRANSPLANTED HEPATOCYTES</B></a> </em><br> <b>M. Kaldenbach</b><sup>1</sup>*, D.F. Tschaharganeh<sup>2</sup>, S. Erschfeld<sup>1</sup>, A. Giebeler<sup>1</sup>, C. Birchmeier<sup>3</sup>, C. Trautwein<sup>1</sup>, K.L. Streetz<sup>1</sup><br> <em><sup>1</sup>Medical Clinic 3, University Hospital Aachen, RWTH Aachen, Aachen, <sup>2</sup>Institute of Pathology, University Hospital Heidelberg, Heidelberg, <sup>3</sup>Department of Signalling Transduction and Developmental Biology, Max Dellbrück Center for Molecuar Medizine, Berlin, Germany. *mkaldenbach@ukaachen.de</em></td><td valign=top><em>946 </td></tr> <tr> <td><a href='Abstract834.htm'><B>EFFICACY OF AUTOLOGOUS MESENCHYMAL STEM CELL TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS: THE PRELIMINARY RESULTS</B></a> </em><br> <b>M. Kantarcioglu</b><sup>1</sup>*, F. Avcu<sup>2</sup>, A. Ozcan<sup>3</sup>, I. Guvenc<sup>4</sup>, A. Uygun<sup>1</sup>, A.U. Ural<sup>2</sup>, S. Bagci<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, <sup>2</sup>Hematology, <sup>3</sup>Pathology, <sup>4</sup>Radiology, Gulhane Military Medical Academy Ankara, Ankara, Turkey. *kantarci@hotmail.com</em></td><td valign=top><em>947 </td></tr> <tr> <td><a href='Abstract835.htm'><B>ACTIVATION OF HUMAN LIVER SINUSOIDAL ENDOTHELIAL CELL BY HUMAN PLATELETS INDUCES HEPATOCYTE PROLIFERATION</B></a> </em><br> <b>T. Kawasaki</b>*, S. Murata, K. Takahashi, R. Nozaki, Y. Ohshiro, N. Ikeda, S. Pak, A. Myronovych, K. Hisakura, K. Fukunaga, T. Oda, R. Sasaki, N. Ohkohchi<br> <em>Department of Surgery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan. *c0730175@md.tsukuba.ac.jp</em></td><td valign=top><em>948 </td></tr> <tr> <td><a href='Abstract836.htm'><B>ADOPTIVE-TRANSFER OF LIVER INJURY AND REGENERATION USING PARABIOSIS-SYSTEM </B></a> </em><br> <b>A. Khalaileh</b><sup>1</sup>*, L. Abu Tair<sup>2</sup>, A. Johnny<sup>2</sup>, N. Muhanna<sup>2</sup>, S. Doron<sup>2</sup>, R. Safadi<sup>2</sup><br> <em><sup>1</sup>Division of Surgery, <sup>2</sup>Liver Unit, Gastroenterology Institute, Division of Medicine, Hadassah University Medical Center, Jerusalem, Israel. *safadi@hadassah.org.il</em></td><td valign=top><em>949 </td></tr> <tr> <td><a href='Abstract837.htm'><B>IMMUNOGENICITY OF MOUSE ESC-DERIVED CELLS IN DIFFERENT STAGES OF HEPATIC LINEAGE DEVELOPMENT: MHC EXPRESSION PROFILES AND IMPLICATION OF ALLOGRAFT REJECTION</B></a> </em><br> G.D. Wu, X. Zhao, <b>A. Klein</b>*<br> <em>Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. *gordon.wu@cshs.org</em></td><td valign=top><em>950 </td></tr> <tr> <td><a href='Abstract838.htm'><B>SPECIES-DEPENDENT BILE ACID-INDUCED APOPTOSIS: A COMPARISON OF PRIMARY HUMAN, MOUSE, AND RAT HEPATOCYTES</B></a> </em><br> <b>P. Kleiss</b><sup>1</sup>*, M. van Wenum<sup>2</sup>, R. Wimmer<sup>1</sup>, T. Vennegeerts<sup>1</sup>, A.F. Hofmann<sup>3</sup>, C. Rust<sup>1</sup><br> <em><sup>1</sup>Department of Medicine 2-Großhadern, University of Munich, Munich, Germany, <sup>2</sup>Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, <sup>3</sup>University of California San Diego, San Diego, CA, USA. *philipp.kleiss@campus.lmu.de</em></td><td valign=top><em>951 </td></tr> <tr> <td><a href='Abstract839.htm'><B>SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 AND 5: DISTINCT REGULATORS IN GROWTH AND DIFFERENTIATION OF HUMAN CHOLANGIOCYTE IN VITRO</B></a> </em><br> <b>A. Komori</b>*, Y. Aiba, M. Nakamura, S. Fujiwara, K. Migita, H. Fujioka, H. Yatsuhashi, H. Ishibashi<br> <em>Clinical Research Center, NHO National Nagasaki Medical Center, Omura, Japan. *komori@nmc.hosp.go.jp</em></td><td valign=top><em>952 </td></tr> <tr> <td><a href='Abstract840.htm'><B>THE COMMON GENETIC RISK FACTOR FOR NON-ALCOHOLIC FATTY LIVER DISEASE DOES NOT INCREASE THE RISK OF DEVELOPING GALLSTONES</B></a> </em><br> <b>M. Krawczyk</b><sup>1</sup>*, F. Grünhage<sup>1</sup>, F. Mihalache<sup>2</sup>, M. Acalovschi<sup>2</sup>, F. Lammert<sup>1</sup><br> <em><sup>1</sup>Department of Medicine II, Saarland University Hospital, Homburg, Germany, <sup>2</sup>Department of Medicine III, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. *marcin.krawczyk@uks.eu</em></td><td valign=top><em>953 </td></tr> <tr> <td><a href='Abstract841.htm'><B>SERUM LEVELS OF CHOLESTEROL PRECURSORS AND PLANT STEROLS INDICATE DECREASED INTESTINAL CHOLESTEROL ABSORPTION BUT INCREASED CHOLESTEROL SYNTHESIS IN CAUCASIAN INDIVIDUALS DEVELOPING GALLSTONES</B></a> </em><br> <b>M. Krawczyk</b><sup>1</sup>*, J.F. Miquel<sup>2</sup>, D. Lütjohann<sup>3</sup>, R. Schirin-Sokhan<sup>4</sup>, F. Lammert<sup>1</sup><br> <em><sup>1</sup>Department of Medicine II, Saarland University Hospital, Homburg, Germany, <sup>2</sup>Department of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago, Chile, <sup>3</sup>Department of Clinical Pharmacology, University Hospital Bonn, Bonn, <sup>4</sup>Department of Medicine III, University Hospital Aachen, Aachen, Germany. *marcin.krawczyk@uks.eu</em></td><td valign=top><em>954 </td></tr> <tr> <td><a href='Abstract842.htm'><B>FOXO3 IS A NEW TARGET GENE FOR TUMOR SUPPRESSORS P53 AND P73 IN REGENERATING LIVER</B></a> </em><br> <b>S. Kurinna</b><sup>1</sup>*, S. Stratton<sup>1</sup>, W.-W. Tsai<sup>1</sup>, W. Gu<sup>2</sup>, G. Darlington<sup>3</sup>, M. Barton<sup>1</sup><br> <em><sup>1</sup>MD Anderson Cancer Center, Houston, TX, <sup>2</sup>Ohio Supercomputer Center, Columbus, OH, <sup>3</sup>Baylor College of Medicine, Houston, TX, USA. *svitlana.m.kurinna@uth.tmc.edu</em></td><td valign=top><em>955 </td></tr> <tr> <td><a href='Abstract843.htm'><B>MIR29 TARGETS THE POTENT PROFIBROGENIC GROWTH FACTORS SUCH AS IGF-I AS WELL AS TWO MEMBERS OF THE VEGF/PDGF FAMILY</B></a> </em><br> <b>M. Kwiecinski</b><sup>1</sup>*, I. Strack<sup>1</sup>, N. Elfimova<sup>1</sup>, A. Noetel<sup>1</sup>, U. Drebber<sup>1</sup>, U. Töx<sup>2</sup>, H.P. Dienes<sup>1</sup>, M. Odenthal<sup>1</sup><br> <em><sup>1</sup>Pathology, <sup>2</sup>Gastroenterology, University Hospital of Cologne, Cologne, Germany. *kw.monika@yahoo.de</em></td><td valign=top><em>956 </td></tr> <tr> <td><a href='Abstract844.htm'><B>INHIBITION OF HEPATIC STELLATE CELL ACTIVATION FOLLOWING ANTI-IGFBPRP1 ADMINISTRATION TO THIOACETAMIDE-TREATED MICE</B></a> </em><br> <b>L.-X. Liu</b><sup>1,2,3</sup>*, G.-X. Qin<sup>4</sup>, H. Zhang<sup>4</sup>, Q. Zhang<sup>4</sup><br> <em><sup>1</sup>Experimental Center of Science and Research of The First Teaching Hospital, <sup>2</sup>Institute of Liver Disease, <sup>3</sup>Key Laboratory of Cell Physiology, Provincial Department of the Ministry of Education, <sup>4</sup>Shanxi Medical University, Taiyuan, China. *lixinliu6@hotmail.com</em></td><td valign=top><em>957 </td></tr> <tr> <td><a href='Abstract845.htm'><B>HEPATIC PROGENITOR CELL (HPCS) EXPANSION IN HUMAN CHRONIC VIRAL HEPATITIS B AND C</B></a> </em><br> <b>S. Lorenzini</b><sup>1</sup>*, E. Grandini<sup>1</sup>, A. Martello Panno<sup>1</sup>, E. Amati<sup>1</sup>, M. Bernardi<sup>1</sup>, S.J. Forbes<sup>2</sup>, P. Andreone<sup>1</sup><br> <em><sup>1</sup>Department of Clinical Medicine, University of Bologna, Bologna, Italy, <sup>2</sup>Medical Research Council (MRC) Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK. *stefania.lorenzini2@unibo.it</em></td><td valign=top><em>958 </td></tr> <tr> <td><a href='Abstract846.htm'><B>REDUCING LATENT CRYOINJURY IN ENCAPSULATED HEPG2S USING AN ENGINEERED FORM OF HEPATOCYTE GROWTH FACTOR, 1K1</B></a> </em><br> <b>I. Massie</b><sup>1</sup>*, J. Ross<sup>1</sup>, E. Gheradi<sup>2</sup>, N. Mallorqui-Fernandez<sup>2</sup>, H. Hodgson<sup>1</sup>, C. Selden<sup>1</sup>, B. Fuller<sup>3</sup><br> <em><sup>1</sup>Centre for Hepatology at the Royal Free, UCL, London, <sup>2</sup>Laboratory for Molecular Biology, MRC, Cambridge, <sup>3</sup>University Department of Surgery, UCL, London, UK. *i.massie@medsch.ucl.ac.uk</em></td><td valign=top><em>959 </td></tr> <tr> <td><a href='Abstract847.htm'><B>CHOLESTEROL REGULATES MITOCHONDRIAL RAFT-LIKE DOMAINS DURING TNF/FAS-MEDIATED HEPATOCELLULAR APOPTOSIS</B></a> </em><br> <b>N. Matias</b><sup>1</sup>*, A. Fernandez<sup>1</sup>, V. Manganelli<sup>2</sup>, A. Colell<sup>1</sup>, A. Tinari<sup>3</sup>, W. Malorni<sup>2</sup>, C. Garcia-Ruiz<sup>1</sup>, M. Sorice<sup>3</sup>, J.C. Fernandez-Checa<sup>1</sup><br> <em><sup>1</sup>Liver Unit, Hospital Clinic, CIBEREHD, IDIBAPS, and IIBB-CSIC, Barcelona, Spain, <sup>2</sup>Department of Technology and Health, Istituto Superiore di Sanitá, <sup>3</sup>Department of Experimental Medicine,  Sapienza University of Rome, Rome, Italy. *nuriamatiash@gmail.com</em></td><td valign=top><em>960 </td></tr> <tr> <td><a href='Abstract848.htm'><B>HYPOXIA INDUCES APELIN RECEPTOR (APJ) EXPRESSION IN A CELL LINE DERIVED FROM HUMAN STELLATE CELLS</B></a> </em><br> <b>P. Melgar-Lesmes</b><sup>1</sup>*, G. Casals<sup>1</sup>, M. Pauta<sup>1</sup>, J. Ros<sup>1</sup>, V. Reichenbach<sup>1</sup>, R. Bataller<sup>2</sup>, M. Morales-Ruiz<sup>1</sup>, W. Jiménez<sup>1</sup><br> <em><sup>1</sup>Biochemistry and Molecular Genetics, <sup>2</sup>Liver Unit-Institut de Malalties Digestives, Hospital Clinic i Provincial de Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain. *melgarpedro@yahoo.com</em></td><td valign=top><em>961 </td></tr> <tr> <td><a href='Abstract849.htm'><B>HEPATIC ENDOGLIN EXPRESSION IS UPREGULATED DURING TRANSDIFFERENTIATION OF HSC TO MFB AND MODULATES PROFIBROGENIC RESPONSES IN MYOFIBROBLAST-LIKE CELLS</B></a> </em><br> <b>S.K. Meurer</b>*, E. Kovalenko, L. Tihaa, R. Weiskirchen<br> <em>Institute of Clinical Chemistry and Pathobiochemistry, RWTH University Hospital Aachen, Aachen, Germany. *smeurer@ukaachen.de</em></td><td valign=top><em>962 </td></tr> <tr> <td><a href='Abstract850.htm'><B>CDKN1C/P57 INDUCES CELL SENESCENCE AND IS REGULATED BY NOTCH TARGET GENE HES1, A PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>M. Minguzzi</b><sup>1,2</sup>*, C. Giovannini<sup>1,3</sup>, L. Gramantieri<sup>1,3</sup>, F. Fornari<sup>1,3</sup>, P. Chieco<sup>1</sup>, L. Bolondi<sup>1,3</sup><br> <em><sup>1</sup>Center for Applied Biomedical Research (CRBA), S.Orsola-Malpighi University Hospital, <sup>2</sup>Department of Biology, <sup>3</sup>Department of Clinical Medicine, University of Bologna, Bologna, Italy. *manuela.minguzzi@gmail.com</em></td><td valign=top><em>963 </td></tr> <tr> <td><a href='Abstract851.htm'><B>MECHANISMS OF P53 REGULATION BY NOTCH SIGNALLING IN HUMAN HEPATOCELLULAR CARCINOMA</B></a> </em><br> <b>M. Minguzzi</b><sup>1,2</sup>*, C. Giovannini<sup>1,3</sup>, L. Gramantieri<sup>1,3</sup>, P. Chieco<sup>1</sup>, K.B. Marcu<sup>1,3,4</sup>, C. Mastroleo<sup>1</sup>, L. Bolondi<sup>1,3</sup><br> <em><sup>1</sup>Center for Applied Biomedical Research (CRBA), S.Orsola-Malpighi University Hospital, <sup>2</sup>Department of Biology, <sup>3</sup>Department of Clinical Medicine, University of Bologna, Bologna, Italy, <sup>4</sup>Biochemestry and Cell Biology Department, Stony Brook University, Stony Brook, NY, USA. *manuela.minguzzi@gmail.com</em></td><td valign=top><em>964 </td></tr> <tr> <td><a href='Abstract852.htm'><B>ACID SPHINGOMYELINASE CONTROLS HEPATIC STELLATE CELL ACTIVATION AND IN VIVO LIVER FIBROSIS</B></a> </em><br> <b>A. Moles</b><sup>1</sup>*, N. Tarrats<sup>1</sup>, A. Morales<sup>1</sup>, M. Dominguez<sup>2</sup>, R. Bataller<sup>1</sup>, J. Caballeria<sup>1</sup>, C. Garcia-Ruiz<sup>1</sup>, J.C. Fernandez-Checa<sup>1</sup>, M. Mari<sup>1</sup><br> <em><sup>1</sup>Liver Unit, Hospital Clínic i Provincial, CIBEREHD, CIBEK, IDIBAPS, IIBB-CSIC, <sup>2</sup>Liver Unit, Hospital Clínic i Provincial, CIBEREHD, CIBEK, IDIBAPS, Barcelona, Spain. *amolestgn@hotmail.com</em></td><td valign=top><em>965 </td></tr> <tr> <td><a href='Abstract853.htm'><B>DOWN-REGULATION OF SREBP-1C IS ASSOCIATED WITH THE DEVELOPMENT OF BURNED-OUT NASH</B></a> </em><br> <b>T. Nagaya</b><sup>1</sup>*, N. Tanaka<sup>2</sup>, M. Komatsu<sup>1</sup>, S. Joshita<sup>1</sup>, T. Umemura<sup>1</sup>, T. Ichijo<sup>1</sup>, A. Matsumoto<sup>1</sup>, K. Yoshizawa<sup>1</sup>, T. Aoyama<sup>3</sup>, E. Tanaka<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, Shinshu University School of Medicine, <sup>2</sup>Metabolic Regulation, <sup>3</sup>Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, Japan. *nagaya@shinshu-u.ac.jp</em></td><td valign=top><em>966 </td></tr> <tr> <td><a href='Abstract854.htm'><B>OXYGEN-MEDIATED ENHANCEMENT OF PRIMARY HEPATOCYTE METABOLISM, FUNCTIONAL POLARIZATION, AND GENE EXPRESSION: ACHIEVING IN VIVO LEVELS OF DRUG CLEARANCE AND HCV INFECTION IN VITRO</B></a> </em><br> <b>Y. Nahmias</b><sup>1,2</sup>*<br> <em><sup>1</sup>The Selim and Rachel Benin School of Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel, <sup>2</sup>Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. *ynahmias@gmail.com</em></td><td valign=top><em>967 </td></tr> <tr> <td><a href='Abstract855.htm'><B>PHARMACOLOGICAL INDUCTION OF PROSTATE APOPTOSIS RESPONSE 4 (PAR-4) PROMOTES APOPTOSIS OF CHOLANGIOCARCINOMA CELLS</B></a> </em><br> A. Torrice<sup>1</sup>, R. Semeraro<sup>1,2</sup>, <b>C. Napoli</b><sup>1,2</sup>*, M. Gatto<sup>1,2</sup>, G. Nuzzo<sup>3</sup>, F. Giuliante<sup>3</sup>, G. Apini<sup>4</sup>, G. Carpino<sup>5</sup>, A. Franchitto<sup>5</sup>, P.B. Berloco<sup>6</sup>, P. Onori<sup>5</sup>, E. Gaudio<sup>5</sup>, D. Alvaro<sup>1,2</sup><br> <em><sup>1</sup>Dept. Clinical Medicine, University of Rome 'Sapienza', Rome, <sup>2</sup>University of Rome 'Sapienza', Polo Pontino, Latina, <sup>3</sup>Dept. Surgery, Hepatobiliary Unit, Catholic University of the Sacred Heart School of Medicine, Rome, Italy, <sup>4</sup>Division Research, Central Texas Veterans Health Care System, Scott & White and Texas A & M University Health Science Center College of Medicine, Temple, TX, USA, <sup>5</sup>Dept. Anatomy, <sup>6</sup>Dept. Surgery, University of Rome 'Sapienza', Rome, Italy. *alessiatorrice@hotmail.it</em></td><td valign=top><em>968 </td></tr> <tr> <td><a href='Abstract856.htm'><B>CYCLIN E1 CONTROLS THE CELL CYCLE ACTIVITY OF HEPATIC STELLATE CELLS AND TRIGGERS FIBROGENESIS IN MICE </B></a> </em><br> <b>Y.A. Nevzorova</b><sup>1</sup>*, J.M. Bangen<sup>1</sup>, N. Gassler<sup>2</sup>, U. Haas<sup>1</sup>, R. Weiskirchen<sup>3</sup>, F. Tacke<sup>1</sup>, P. Sicinski<sup>4</sup>, C. Trautwein<sup>1</sup>, C. Liedtke<sup>1</sup><br> <em><sup>1</sup>Department of Medicine III, <sup>2</sup>Institute of Pathology, <sup>3</sup>Institute of Clinical Chemistry and Pathobiochemistry, University Hospital Aachen, Aachen, Germany, <sup>4</sup>Dana-Farber Cancer Institute, Boston, MA, USA. *nevzorovaj@googlemail.com</em></td><td valign=top><em>969 </td></tr> <tr> <td><a href='Abstract857.htm'><B>NEURONAL MICRORNAS, UPREGULATED DURING MYOFIBROBLASTIC DIFFERENTIATION, TARGET THE PLURIPOTENCY FACTOR LIN-28</B></a> </em><br> <b>A. Noetel</b>*, I. Strack, M. Kwiecinski, H.P. Dienes, M. Odenthal<br> <em>Institute for Pathology, University Hospital of Cologne, Cologne, Germany. *andrea.noetel@uni-koeln.de</em></td><td valign=top><em>970 </td></tr> <tr> <td><a href='Abstract858.htm'><B>MICRORNA-29B SUPPRESSES TYPE I COLLAGEN AND SP1 EXPRESSION IN INTERFERON-TREATED STELLATE CELLS</B></a> </em><br> <b>T. Ogawa</b><sup>1</sup>*, M. Iizuka<sup>1</sup>, Y. Sekiya<sup>1,2</sup>, K. Yoshizato<sup>1,3</sup>, K. Ikeda<sup>4</sup>, N. Kawada<sup>1</sup><br> <em><sup>1</sup>Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, <sup>2</sup>Toray Industries Inc., Kanagawa, <sup>3</sup>PhoenixBio Co. Ltd., Hiroshima, <sup>4</sup>Department of Functional Anatomy, Graduate School of Medicine, Nagoya City University, Aichi, Japan. *tomo123@med.osaka-cu.ac.jp</em></td><td valign=top><em>971 </td></tr> <tr> <td><a href='Abstract859.htm'><B>SERUM CONCENTRATION OF FAS, FASL, CYTOCHROME C AND M30-NEOEPITOPE OF CYTOKERATIN-18 IN CHRONIC HEPATITIS C</B></a> </em><br> <b>A. Parfieniuk-Kowerda</b>*, T.W. Lapinski, M. Rogalska-Plonska, M. Rogalska, J. Pogorzelska, R. Flisiak<br> <em>Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland. *anna.parfieniuk@gmail.com</em></td><td valign=top><em>972 </td></tr> <tr> <td><a href='Abstract860.htm'><B>CANNABINOID RECEPTOR TYPE 1 EXPRESSION MODULATES ALCOHOL-INDUCED LIVER FIBROSIS: ROLE OF ACETALDEHYDE</B></a> </em><br> <b>E. Patsenker</b><sup>1</sup>*, T. Wissniowski<sup>2</sup>, G. Millonig<sup>3</sup>, S. Mueller<sup>3</sup>, M. Stoll<sup>2</sup>, M. Ocker<sup>2</sup>, H.K. Seitz<sup>3</sup>, F. Stickel<sup>1</sup><br> <em><sup>1</sup>Institute of Clinical Pharmacology and Visceral Research, University of Bern, Bern, Switzerland, <sup>2</sup>Department of Medicine I, University of Erlangen-Nuremberg, Erlangen, <sup>3</sup>Department of Medicine and Center for Alcohol Research, Liver Disease and Nutrition, Salem Medical Center, University of Heidelberg, Heidelberg, Germany. *eleonora.patsenker@ikp.unibe.ch</em></td><td valign=top><em>973 </td></tr> <tr> <td><a href='Abstract861.htm'><B>NUCLEAR FACTOR KAPPA B IS REQUIRED FOR SERUM FREE INDUCED ACTIVATION AND CHROMATIN ACCESSIBILITY OF DAMAGE-REGULATED AUTOPHAGY MODULATOR PROMOTER IN LIVER CANCER CELLS</B></a> </em><br> <b>N. Peihua</b><sup>1</sup>*, W. Jiayi<sup>2</sup>, G. Zhidong<sup>2</sup>, F. Qishi<sup>2</sup><br> <em><sup>1</sup>Faculty of Medical Laboratory, <sup>2</sup>Department of Clinical Laboratory, Ruijin Hospital/Shanghai Jiaotong University Medical School, Shanghai, China. *nphxh@hotmail.com</em></td><td valign=top><em>974 </td></tr> <tr> <td><a href='Abstract862.htm'><B>ACTIVATION OF THE HEPATIC APELIN SYSTEM IS OF MAJOR RELEVANCE IN EARLY STAGES OF LIVER FIBROSIS</B></a> </em><br> <b>V. Reichenbach</b>*, J. Ros, G. Fernández-Varo, G. Casals, P. Melgar-Lesmes, M. Pauta, M. Morales-Ruiz, W. Jiménez<br> <em>Biochemistry and Molecular Genetics Service, Hospital Clinic i Provincial de Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain. *vedrana.reichenbach@gmail.com</em></td><td valign=top><em>975 </td></tr> <tr> <td><a href='Abstract863.htm'><B>INSULIN INDUCES A SWELLING-DEPENDENT EGFR ACTIVATION </B><B>VIA THE INTEGRIN SYSTEM IN THE PERFUSED RAT LIVER</B></a> </em><br> <b>R. Reinehr</b>*, A. Sommerfeld, D. Häussinger<br> <em>Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, Germany. *reinehr@uni-duesseldorf.de</em></td><td valign=top><em>976 </td></tr> <tr> <td><a href='Abstract864.htm'><B>INHIBITION OF NITRIC OXIDE SYNTHESIS DURING INDUCED CHOLESTASIS AMELIORATES HEPATOCELLULAR INJURY BY FACILITATING S-NITROSOTHIOL HOMEOSTASIS</B></a> </em><br> L.M. López-Sánchez<sup>1</sup>, F.J. Corrales<sup>2</sup>, M. Barcos<sup>3</sup>, I. Espejo<sup>3</sup>, J.R. Muñoz-Castañeda<sup>1</sup>, <b>A. Rodríguez-Ariza</b><sup>1</sup>*<br> <em><sup>1</sup>Hospital Universitario Reina Sofía, Unidad de Investigación, IMIBIC, Córdoba, <sup>2</sup>Universidad de Navarra, Hepatology and Gene Therapy Unit, Pamplona, <sup>3</sup>Hospital Universitario Reina Sofía, Servicio de Análisis Clínicos, Córdoba, Spain. *antonio.rodriguez.exts@juntadeandalucia.es</em></td><td valign=top><em>977 </td></tr> <tr> <td><a href='Abstract865.htm'><B>S-NITROSOGLUTATHIONE (GSNO) IS A KEY CONTRIBUTOR TO THE HYPERCHOLERETIC EFFECT OF URSODEOXYCHOLIC ACID (UDCA)</B></a> </em><br> <b>C.M. Rodriguez-Ortigosa</b><sup>1,2</sup>*, J.M. Bañales<sup>1,2</sup>, I. Olivas<sup>1</sup>, I. Uriarte<sup>1,2</sup>, F.J. Corrales<sup>1</sup>, J.F. Medina<sup>1,2,3</sup>, J. Prieto<sup>1,2,3</sup><br> <em><sup>1</sup>Division of Hepatology and Gene Therapy, CIMA-University of Navarra, <sup>2</sup>CIBERehd, Instituto Carlos III, <sup>3</sup>Liver Unit, University Clinic, Pamplona, Spain. *crodriguez@unav.es</em></td><td valign=top><em>978 </td></tr> <tr> <td><a href='Abstract866.htm'><B>LIVER FIBROSIS IN CXCR3 KNOCKOUT MICE IS ASSOCIATED WITH INCREASED NEOANGIOGENESIS</B></a> </em><br> <b>H. Sahin</b>*, P. Schmitz, C. Trautwein, H.E. Wasmuth<br> <em>Medizinische Klinik III, Universitätsklinikum Aachen, Aachen, Germany. *hasahin@ukaachen.de</em></td><td valign=top><em>979 </td></tr> <tr> <td><a href='Abstract867.htm'><B>HEPCIDIN IS RESPONSIVE TO ORAL IRON CHALLENGE IN HEALTHY VOLUNTEERS</B></a> </em><br> <b>A. Sangwaiya</b><sup>1</sup>*, M. Busbridge<sup>2</sup>, V. Manglam<sup>1</sup>, M. Thursz<sup>3</sup>, J. Arnold<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, Ealing Hospital NHS Trust, <sup>2</sup>Clinical Chemistry, Charing Cross Hospital NHS Trust, <sup>3</sup>Department of Hepatology, St Mary's Hospital, Imperial College, London, UK. *asangwaiya@yahoo.com</em></td><td valign=top><em>980 </td></tr> <tr> <td><a href='Abstract868.htm'><B>EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN CHOLANGIOCYTES DOES NOT CONTRIBUTE TO THE POPULATION OF ±-SMA<SUP>+</SUP> MYOFIBROBLASTS IN EXPERIMENTAL MODELS OF LIVER FIBROSIS</B></a> </em><br> <b>D. Scholten</b><sup>1,2</sup>*, A. Scholten<sup>2</sup>, C. Östereicher<sup>2</sup>, D.A. Brenner<sup>2</sup>, T. Kisseleva<sup>2</sup><br> <em><sup>1</sup>Department of Internal Medicine III, RWTH Aachen, Aachen, Germany, <sup>2</sup>Department of Medicine, University of California, San Diego, CA, USA. *dscholten@ukaachen.de</em></td><td valign=top><em>981 </td></tr> <tr> <td><a href='Abstract869.htm'><B>BMI1 IS A MARKER OF ACTIVATED LIVER PROGENITOR CELLS</B></a> </em><br> <b>B.A. Schotanus</b><sup>1</sup>*, B. Spee<sup>1,2</sup>, H.S. Kruitwagen<sup>1</sup>, B.B. Brinkhof<sup>1</sup>, T.S.G.A.M. van den Ingh<sup>3</sup>, L.C. Penning<sup>1</sup>, T. Roskams<sup>2</sup><br> <em><sup>1</sup>Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands, <sup>2</sup>Department of Morphology and Molecular Pathology, University Hospitals Leuven, Leuven, Belgium, <sup>3</sup>TCCI Consultancy, Utrecht, The Netherlands. *b.a.schotanus@uu.nl</em></td><td valign=top><em>982 </td></tr> <tr> <td><a href='Abstract870.htm'><B>LIVER FUNCTIONAL COMPENSATION AFTER PARTIAL HEPATECTOMY IS DEPENDENT ON THE ENHANCED HISTONE ACETYLATION IN HEPATOCYTES</B></a> </em><br> <b>Y. Shi</b><sup>1</sup>*, H. Sun<sup>1</sup>, J. Bao<sup>1</sup>, H. Bu<sup>1,2</sup><br> <em><sup>1</sup>Laboratory of Transplant Engineering and Immunology, <sup>2</sup>Department of Pathology, West China Hospital, Sichuan University, Chengdu, China. *shiyujun@scu.edu.cn</em></td><td valign=top><em>983 </td></tr> <tr> <td><a href='Abstract871.htm'><B>ELEVATED ENDOCANNABINOID LEVELS DURING LIVER FIBROGENESIS ARE DRIVEN BY DIMINISHED HEPATIC EXPRESSION AND ACTIVITY OF ENDOCANNABINOID DEGRADING ENZYMES</B></a> </em><br> <b>S.V. Siegmund</b><sup>1,2</sup>*, A. Wojtalla<sup>1,2,3</sup>, F. Herweck<sup>2</sup>, A. Zimmer<sup>3</sup>, M.V. Singer<sup>2</sup><br> <em><sup>1</sup>Medical Department I, University of Bonn, Bonn, <sup>2</sup>Medical Department II, University Hospital Mannheim, Mannheim, <sup>3</sup>Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany. *soeren.siegmund@ukb.uni-bonn.de</em></td><td valign=top><em>984 </td></tr> <tr> <td><a href='Abstract872.htm'><B>THE NOVEL ENDOCANNABINOID VIRODHAMINE SELECTIVELY INDUCES CELL DEATH IN HEPATIC STELLATE CELLS</B></a> </em><br> A. Wojtalla<sup>1,2,3</sup>, F. Herweck<sup>3</sup>, M.V. Singer<sup>3</sup>, A. Zimmer<sup>2</sup>, <b>S.V. Siegmund</b><sup>1,3</sup>*<br> <em><sup>1</sup>Department of Medicine I, <sup>2</sup>Institute of Molecular Psychiatry, University of Bonn, Bonn, <sup>3</sup>Medical Department II, University Hospital Mannheim, Mannheim, Germany. *soeren.siegmund@ukb.uni-bonn.de</em></td><td valign=top><em>985 </td></tr> <tr> <td><a href='Abstract873.htm'><B>INTRAHEPATIC CHOLESTATIS OF PREGNANCY: A  IN VIVO MODEL OF THE HEPATIC CLEARANCE OF ADIPONECTIN</B></a> </em><br> <b>G. Soardo</b><sup>1</sup>*, L. Driul<sup>2</sup>, A. Carnelutti<sup>1</sup>, L. Domenis<sup>1</sup>, D. Cappello<sup>1</sup>, D. De Silvestri<sup>1</sup>, D. Marchesoni<sup>2</sup>, L.A. Sechi<sup>1</sup>, D. Donnini<sup>1</sup><br> <em><sup>1</sup>Internal Medicine Liver Unit DPMSC, University Hospital Udine, <sup>2</sup>Institute of Obstetrics and Gynecology DSS, University of Udine, Udine, Italy. *c.predicort@alice.it</em></td><td valign=top><em>986 </td></tr> <tr> <td><a href='Abstract874.htm'><B>UREA INDUCES A NON-OSMOTIC ACTIVATION OF THE INTEGRIN SYSTEM AND SUBSEQUENT SIGNALING CASCADES OTHERWISE INDUCED BY CELL SWELLING IN THE PERFUSED RAT LIVER</B></a> </em><br> <b>A. Sommerfeld</b><sup>1</sup>*, R. Reinehr<sup>1</sup>, S. vom Dahl<sup>2</sup>, D. Häussinger<sup>1</sup><br> <em><sup>1</sup>Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, <sup>2</sup>Clinic for Internal Medicine, St. Franziskus Hospital, Cologne, Germany. *annika@freakmail.de</em></td><td valign=top><em>987 </td></tr> <tr> <td><a href='Abstract875.htm'><B>S-NITROSO-N-ACETYLCYSTEINE (SNAC), A NITRIC OXIDE DONOR, MODULATED HEPATIC STELLATE CELLS (HSCS) ACTIVITY: A NEW ANTIFIBROGENIC AGENT</B></a> </em><br> <b>J.T. Stefano</b><sup>1</sup>*, B. Cogliati<sup>2</sup>, F.S. Oliveira<sup>3</sup>, V.M. Lima<sup>1</sup>, G.F. de Souza<sup>4</sup>, C. Uribe<sup>3</sup>, M.G. de Oliveira<sup>4</sup>, U. Matte<sup>3</sup>, M.L.Z. Dagli<sup>2</sup>, M.R. Álvares-da-Silva<sup>5</sup>, T.R. Silveira<sup>3</sup>, F.J. Carrilho<sup>1</sup>, C.P. Oliveira<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, University of Sao Paulo School of Medicine, <sup>2</sup>Department of Pathology, University of São Paulo School of Veterinary Medicine and Animal Sciences, São Paulo, <sup>3</sup>Department of Internal Medicine and Pediatrics, Federal University of Rio Grande do Sul, Porto Alegre, <sup>4</sup>Institute of Chemistry, State University of Campinas (UNICAMP), Campinas, <sup>5</sup>Department of Internal Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. *jstefano@usp.br</em></td><td valign=top><em>988 </td></tr> <tr> <td><a href='Abstract876.htm'><B>BENEFICIAL PARACRINE EFFECTS OF CANNABINOID CB2 RECEPTORS ON LIVER INJURY AND REGENERATION</B></a> </em><br> <b>F. Teixeira-Clerc</b><sup>1</sup>*, M.-P. Belot<sup>1</sup>, S. Manin<sup>1</sup>, V. Deveaux<sup>1</sup>, A. Zimmer<sup>2</sup>, T. Tordjmann<sup>3</sup>, A. Mallat<sup>1,4</sup>, S. Lotersztajn<sup>1,4</sup><br> <em><sup>1</sup>INSERM U955, Creteil, France, <sup>2</sup>Dept of Molecular Psychiatry, University of Bonn, Bonn, Germany, <sup>3</sup>INSERM U757, Orsay, <sup>4</sup>AP-HP, Groupe Henri Mondor-Albert Chenevier, Service d'Hepatologie et de Gastroenterologie, Creteil, France. *fatima.clerc@inserm.fr</em></td><td valign=top><em>989 </td></tr> <tr> <td><a href='Abstract877.htm'><B>LIVER STEM CELL INVOLVEMENT IN HEPATIC FIBROSIS ONSET AND PROGRESSION</B></a> </em><br> L. Amicone<sup>1</sup>, A. Conigliaro<sup>1</sup>, F. Garibaldi<sup>1</sup>, C. Cicchini<sup>1</sup>, A. Marchetti<sup>1</sup>, <b>M. Tripodi</b><sup>1,2</sup>*<br> <em><sup>1</sup>Cellular Biotechnologies and Haematology, Sapienza of Rome, <sup>2</sup>National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy. *tripodi@bce.uniroma1.it</em></td><td valign=top><em>990 </td></tr> <tr> <td><a href='Abstract878.htm'><B>INTERINDIVIDUAL VARIABILITY OF BILE ACID GLUCURONIDATION AND HEPATIC UDP-GLUCURONOSYLTRANSFERASE EXPRESSION IN RESPONSE TO RIFAMPICIN: <I>IN VIVO</I> AND <I>IN VITRO</I> EVIDENCES</B></a> </em><br> <b>J. Trottier</b><sup>1</sup>*, A. Bialek<sup>2</sup>, P. Caron<sup>1</sup>, P. Milkiewicz<sup>2</sup>, O. Barbier<sup>1</sup><br> <em><sup>1</sup>Laval University, Quebec, QC, Canada, <sup>2</sup>Pomeranian Medical School, Szczecin, Poland. *jocelyn.trottier@crchul.ulaval.ca</em></td><td valign=top><em>991 </td></tr> <tr> <td><a href='Abstract879.htm'><B>IMPACT OF INTRAVENOUS GLUCOSE LOAD ON BILE SALT TRANSPORTERS IN CRITICALLY ILL RABBITS</B></a> </em><br> <b>Y.-M. Vanwijngaerden</b>*, S. Derde, A. Keereman, L. Langouche, L. Mebis, H. Vervenne, G. Van den Berghe, D. Mesotten<br> <em>Intensive Care Medicine, KULeuven, Leuven, Belgium. *yoo-mee.vanwijngaerden@med.kuleuven.be</em></td><td valign=top><em>992 </td></tr> <tr> <td><a href='Abstract880.htm'><B>THE EFFECT OF IMPAIRED HEPATIC LIPOGENESIS ON LIVER REGENERATION IN A MODEL OF DIPEPTIDYL PEPTIDASE 4-DEFICIENT RATS</B></a> </em><br> <b>A. Waizbard</b><sup>1</sup>*, M. Schnell<sup>2</sup>, I. Zvibel<sup>3</sup>, A. Phillips<sup>3</sup>, Z. Halpern<sup>3</sup>, R. Oren<sup>3</sup><br> <em><sup>1</sup>Internal Medicine I, <sup>2</sup>Internal Medicine B, <sup>3</sup>Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. *waizbard@gmail.com</em></td><td valign=top><em>993 </td></tr> <tr> <td><a href='Abstract881.htm'><B>IL-13 INDUCES CTGF EXPRESSION IN RAT HEPATIC STELLATE CELLS VIA ACTIVATING OF SMAD SIGNALING</B></a> </em><br> Y. Liu, C. Meyer, A. Mueller, F. Herweck, C. Stump, M.V. Singer, S. Dooley, <b>H. Weng</b>*<br> <em>Molecular Hepatology - Alcohol Dependent Diseases, II. Medical Clinic Faculty of Medicine Mannheim University of Heidelberg, Mannheim, Germany. *honglei.weng@med.ma.uni-heidelberg.de</em></td><td valign=top><em>994 </td></tr> <tr> <td><a href='Abstract882.htm'><B>VASCULAR ADHESION PROTEIN-1 (VAP 1): A KEY PLAYER IN THE MODULATION OF HEPATIC FIBROSIS</B></a> </em><br> <b>C.J. Weston</b><sup>1</sup>*, E.L. Haughton<sup>1</sup>, N.M. Westerlund<sup>1,2</sup>, L.C. Claridge<sup>1</sup>, J. Pravin<sup>1</sup>, D.J. Smith<sup>2</sup>, D.H. Adams<sup>1</sup><br> <em><sup>1</sup>Centre for Liver Research, The University of Birmingham, Birmingham, UK, <sup>2</sup>Biotie Therapies Corp., Turku, Finland. *c.j.weston@bham.ac.uk</em></td><td valign=top><em>995 </td></tr> <tr> <td><a href='Abstract883.htm'><B>HUMAN POLYCYSTIC LIVER CYST FLUID INDUCED CHOLANGIOCYTE PROLIFERATION IS REVERSED BY LANREOTIDE IN A SOMATOSTATIN RECEPTOR 5 AND PHOSPHODIESTERASE 4D DEPENDENT MECHANISM</B></a> </em><br> <b>J. Woudenberg</b>*, M.J. Janssen, I. Worm, R.H. Te Morsche, M. Chrispijn, J.P.H. Drenth<br> <em>Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. *j.woudenberg@mdl.umcn.nl</em></td><td valign=top><em>996 </td></tr> <tr> <td><a href='Abstract884.htm'><B>HESPERIDIN</B> <B>ATTENUATES LIPOPOLYSACCHARIDE-INDUCED FULMINANT HEPATIC FAILURE IN D-GALACTOSAMINE-SENSITIZED MICE</B></a> </em><br> J.-Y. Wan<sup>1</sup>, X. Gong<sup>2</sup>, F.-L. Luo<sup>3</sup>, H.-Z. Li<sup>4</sup>, <b>L. Zhang</b><sup>5</sup>*<br> <em><sup>1</sup>Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, <sup>2</sup>Department of Anatomy, <sup>3</sup>Department of Pharmacy, The first Afûliated Hospital of Chongqing Medical University, <sup>4</sup>Department of Pharmacology, <sup>5</sup>Department of Pathophysiology, Chongqing Medical University, Chongqing, China. *zhanglipp@yahoo.com.cn</em></td><td valign=top><em>997 </td></tr> <tr> <td><a href='Abstract885.htm'><B>CENTROMERE PROTEIN A IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND INVOLVED IN CELL CYCLE REGULATION</B></a> </em><br> Y. Li, Z. Zhu, S. Zhang, D. Yu, H. Yu, L. Liu, X. Cao, L. Wang, H. Gao, <b>M. Zhu</b>*<br> <em>Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai, China. *mhzhu2000@hotmail.com</em></td><td valign=top><em>998 </td></tr> <tr> <td><a href='Abstract886.htm'><B>HUMAN MONOCYTE SUBSETS ACCUMULATE INTRAHEPATICALLY IN LIVER CIRRHOSIS AND DIFFERENTIALLY INTERACT WITH HEPATIC STELLATE CELLS </B></a> </em><br> <b>H.W. Zimmermann</b><sup>1</sup>*, S. Seidler<sup>1</sup>, J. Nattermann<sup>2</sup>, N. Gassler<sup>3</sup>, C. Hellerbrand<sup>4</sup>, R. Weiskirchen<sup>5</sup>, C. Trautwein<sup>1</sup>, F. Tacke<sup>1</sup><br> <em><sup>1</sup>Medizinische Klinik III, Universitätsklinikum Aachen, Aachen, <sup>2</sup>Universität Bonn, Bonn, <sup>3</sup>Institut für Pathologie, Universitätsklinikum Aachen, Aachen, <sup>4</sup>Universität Regensburg, Regensburg, <sup>5</sup>Institut für Klinische Chemie und Pathobiochemie, Universitätsklinikum Aachen, Aachen, Germany. *henzimmermann@ukaachen.de</em></td><td valign=top><em>999 </td></tr> <tr> <td><a href='Abstract887.htm'><B>ROLE OF CALCIUM-CALMODULIN PATHWAY IN ESTRADIOL-17ß-GLUCURONIDE INDUCED IMPAIRMENT OF CANALICULAR SECRETION IN ISOLATED RAT HEPATOCYTE COUPLETS</B></a> </em><br> <b>A. Zucchetti</b>*, F.D. Toledo, I.R. Barosso, E.J. Ochoa, F.A. Crocenzi, E.J. Sánchez Pozzi<br> <em>Instituto de Fisiología Experimental, Rosario, Argentina. *zucchetti@ifise-conicet.gov.ar</em></td><td valign=top><em>1000 </td></tr> </table><a href='index.asp'>Back</a><br> <p>&nbsp;</p> <p>&nbsp;</p></td> </tr> </table> </body> </html>